Thermo Fisher Scientific Inc. (TMO) Gross Margin: 39.41%
Is Thermo Fisher Scientific Inc.’s gross margin high or low?
Thermo Fisher Scientific Inc.'s gross margin of 39.41% is in line with its 5-year average of 43.54%, near the low end of its 5-year range (37.66%–50.07%).
The gross margin for Thermo Fisher Scientific Inc. (TMO) is 39.41% as of Wednesday, June 10, 2026. It is below its 12-month average by 0.23% (39.50%).
TMO Gross Margin Chart
TMO Average Gross Margin Chart
TMO Current vs Average Gross Margin Chart
TMO Gross Margin Metrics
GROSS MARGIN
39.41%
GROSS MARGIN AVG TTM
39.50%
GROSS MARGIN AVG 3Y
40.36%
GROSS MARGIN AVG 5Y
43.54%
GROSS MARGIN AVG 10Y
44.57%
GROSS MARGIN AVG 15Y
44.02%
GROSS MARGIN AVG 20Y
43.64%
CURRENT VS TTM AVG
-0.23%
CURRENT VS 3Y AVG
-2.36%
CURRENT VS 5Y AVG
-9.50%
CURRENT VS 10Y AVG
-11.57%
CURRENT VS 15Y AVG
-10.47%
CURRENT VS 20Y AVG
-9.69%
TMO Competitors' Gross Margin
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $179.45B | 39.41% | 39.50% | 40.36% | 43.54% |
| Amgen Inc. (AMGN) | $183.75B | 71.46% | 66.16% | 69.53% | 71.51% |
| Abbott Laboratories (ABT) | $154.66B | 56.38% | 53.17% | 51.86% | 51.92% |
| Gilead Sciences, Inc. (GILD) | $151.21B | 79.35% | 78.55% | 78.10% | 78.28% |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 66.29% | 66.73% | 66.82% | 67.04% |
| Pfizer Inc. (PFE) | $146.36B | 69.35% | 68.05% | 62.23% | 63.06% |
| Danaher Corporation (DHR) | $130.25B | 60.68% | 60.22% | 59.98% | 59.48% |
| CVS Health Corporation (CVS) | $125.16B | 13.87% | 13.78% | 14.92% | 15.96% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 68.75% | 62.23% | 59.55% | 57.82% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 86.28% | 85.57% | 86.56% | 87.08% |
Gross Margin Analysis
Gross Margin
39.4%
(Revenue - COGS) / Revenue
Thermo Fisher Scientific Inc. Gross Margin Formula & Definition
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. Gross Margin FAQ
- What is the gross margin for Thermo Fisher Scientific Inc. (TMO)?
- The gross margin for TMO stock is 39.41%.
- Is Thermo Fisher Scientific Inc.'s gross margin high or low?
- Thermo Fisher Scientific Inc.'s gross margin of 39.41% is in line with its 5-year average of 43.54%, near the low end of its 5-year range (37.66%–50.07%).
- What is the TTM average gross margin for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average gross margin for TMO stock is 39.50%.
- What is the 3Y average gross margin for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average gross margin for TMO stock is 40.36%.
- What is the 5Y average gross margin for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average gross margin for TMO stock is 43.54%.
- What is the 10Y average gross margin for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average gross margin for TMO stock is 44.57%.
- What is the 15Y average gross margin for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average gross margin for TMO stock is 44.02%.
- What is the 20Y average gross margin for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average gross margin for TMO stock is 43.64%.
Thermo Fisher Scientific Inc. Gross Margin History
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 37.66% |
| 2024-12-31 | 41.34% |
| 2023-12-31 | 40.12% |
| 2022-12-31 | 42.33% |
| 2021-12-31 | 50.07% |
| 2020-12-31 | 49.75% |
| 2019-12-31 | 44.41% |
| 2018-12-31 | 45.11% |
| 2017-12-31 | 46.27% |
| 2016-12-31 | 46.96% |
| 2015-12-31 | 46.20% |
| 2014-12-31 | 46.69% |
| 2013-12-31 | 42.98% |
| 2012-12-31 | 43.28% |
| 2011-12-31 | 41.50% |
| 2010-12-31 | 39.62% |
| 2009-12-31 | 40.26% |
| 2008-12-31 | 40.41% |
| 2007-12-31 | 39.95% |
| 2006-12-31 | 44.49% |
| 2005-12-31 | 47.00% |
| 2004-12-31 | 46.04% |
| 2003-12-31 | 45.21% |
| 2002-12-31 | 44.45% |
| 2001-12-31 | 43.81% |
| 2000-12-31 | 44.81% |
| 1999-12-31 | 48.81% |
| 1998-12-31 | 47.65% |
| 1997-12-31 | 48.36% |
| 1996-12-31 | 47.40% |
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper